InsiderFlow

FBLG

FibroBiologics, Inc. Common Stock$0.95-0.07 (-6.86%)
Prev Close$1.02·MCap$3.0M·P/E—·Vol108.0K·Yield—
▲

Buys (12M)

3

$89.6K

▼

Sells (12M)

0

$0.00

◆

Net Activity

Net Buyer

$89.6K

●

Active Insiders

2

last 12 mo

Over the past 12 months, insider activity at FibroBiologics, Inc. Common Stock (FBLG) has been exclusively buying, with 3 insider purchases totaling $89.6K and 0 insider sales totaling $0.00. The most recent insider transaction was by Davis Jason (officer: Chief Financial Officer), who purchased $29.0K worth of shares on Mar 3, 2026. FibroBiologics, Inc. Common Stock operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $3.0M.

FBLG Insider Trading Activity

DateInsiderTypeValue
Mar 3, 2026 Davis JasonBuy$29.0K3.3% OS
Mar 2, 2026 GARCIA RUBEN ABuy$13.1K1.9% OS
Dec 11, 2025 GARCIA RUBEN ABuy$47.6K6.7% OS
May 27, 2025 Khoja HamidBuy$16.8K1.0% OS
Aug 12, 2024 Khoja HamidBuy$19.0K
Aug 12, 2024 O'HEERON PETEBuy$16.3K

FBLG Insider Buying Activity

The following table shows recent insider purchases of FibroBiologics, Inc. Common Stock (FBLG) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Mar 3, 2026 Davis JasonBuy$29.0K3.3% OS
Mar 2, 2026 GARCIA RUBEN ABuy$13.1K1.9% OS
Dec 11, 2025 GARCIA RUBEN ABuy$47.6K6.7% OS
May 27, 2025 Khoja HamidBuy$16.8K1.0% OS
Aug 12, 2024 Khoja HamidBuy$19.0K
Aug 12, 2024 O'HEERON PETEBuy$16.3K

FBLG Insider Selling Activity

The following table shows recent insider sales of FibroBiologics, Inc. Common Stock (FBLG) stock reported via SEC Form 4 filings.

No insider selling activity found for FBLG in the last 12 months.

FBLG Insiders

Davis Jason

officer: Chief Financial Officer

Bought $29.0K
1 tradesLast: Mar 3, 2026
GARCIA RUBEN A

officer: General Counsel

Bought $60.7K
2 tradesLast: Mar 2, 2026
Khoja Hamid

Chief Scientific Officer

Bought $35.8K
2 tradesLast: May 27, 2025
O'HEERON PETE

Chief Executive Officer

Bought $16.3K
1 tradesLast: Aug 12, 2024